Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women
Andrew Teo, Louise M Randall, Mwayiwawo Madanitsa, Victor Mwapasa, Linda Kalilani Phiri, Carole Khairallah, Christelle Buffet, Amalia Karahalios, David L Narum, Feiko O Ter Kuile, Stephen J Rogerson
Scientific Reports | NATURE PUBLISHING GROUP | Published : 2019
Awarded by National Health and Medical Research council of Australia
Awarded by European and Developing Countries Clinical Trial Partnership
Awarded by Malaria in Pregnancy Consortium - Bill & Melinda Gates Foundation
We thank the pregnant women for their participation in the study. We are grateful to Prof James Beeson and Christine Langer for providing merozoite antigens, MSP 3 and PfRh2, Prof Robin Anders for merozoite antigen, MSP2 and Dr. Joseph Smith for DBL5. We thank Prof Graham Brown for input into the study design and interpretation. This study was supported by National Health and Medical Research council of Australia awarded to SJR and Graham Brown, Grant Number: 10244441. The parent trial was supported by the European and Developing Countries Clinical Trial Partnership, Grant Number: IP.2007.31080.003. Sample collection was supported in part by Malaria in Pregnancy Consortium, which receives funding from the Bill & Melinda Gates Foundation, Grant Number: 46099. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.